SSSophie Sagnier

Sophie Sagnier

*This is an algorithmically generated author record based on publicly available information.

Research Interests


Sophie Sagnier has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Ben Berkhout

    Department of Medical Microbiology Laboratory of Experimental Virology Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, the Netherlands

    1 shared publication
  • Dirk Geerts

    Department of Pediatric Oncology/Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

    1 shared publication
  • Julia Jm Eekels

    Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105, AZ Amsterdam, The Netherlands

    1 shared publication
  • Martine Biard-Piechaczyk

    CNRS–UMR

    1 shared publication
  • Rienk E. Jeeninga

    Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, PO Box 22700, DE Amsterdam, 1100, The Netherlands.

    1 shared publication

Latest Publications

  • Open Access

    Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors

    by Julia Jm Eekels, Sophie Sagnier, Dirk Geerts, Rienk E Jeeninga, Martine Biard-Piechaczyk, Ben Berkhout

    Autophagy is a cellular process leading to the degradation of cytoplasmic components such as organelles and intracellular pathogens. It has been shown that HIV-1 relies on several components of the autophagy pathway for its replication, but the virus also blocks late steps of autophagy to prevent its degradation. We generated stable knockdown T cell lines for 12 autophagy factors and analyzed the impact on HIV-1 replication. RNAi-mediated knockdown of 5 autophagy factors resulted in inhibition of HIV-1 replication. Autophagy analysis confirmed a specific defect in the autophagy pathway for 4 of these 5 factors. We also scored the impact on cell viability, but no gross effects were observed. Upon simultaneous knockdown of 2 autophagy factors (Atg16 and Atg5), an additive inhibitory effect was scored on HIV-1 replication. Stable knockdown of several autophagy factors inhibit HIV-1 replication without any apparent cytotoxicity. We therefore propose that targeting of the autophagy pathway can be a novel therapeutic approach against HIV-1